Slingshot members are tracking this event:
Ziopharm (ZIOP) estimates completion of Phase 1 study of Autologous CD19-specific T Cells Infusion in patients with Lymphoma in late 2018
Slingshot Insights Explained
Aug 08, 2019
Don’t see a project related to the catalyst you care about?
Related Keywords Phase 1 Study, Cd19, T Cell Infusion, Lymphoma, Interleukin-2, Gene Transfer, Leukapheresis, Stem Cell Transplant, Carmustine, Etoposide, Melphalan, Cytarabine